TPD52 |
MAL2 |
||
---|---|---|---|
Gene Name | tumor protein D52 | mal, T-cell differentiation protein 2 (gene/pseudogene) | |
Image | No pdb structure | No pdb structure | |
Gene Ontology Annotations | Cellular Component | ||
Molecular Function | |||
Biological Process | |||
Pathways | |||
Drugs | |||
Diseases | |||
GWAS |
|
|
|
Protein-Protein Interactions | 8 interactors: ANXA6 MAL2 SENP2 SOCS2 SRPK2 TPD52L1 TPD52L2 TPD52L3 | 15 interactors: ABCG8 ARFIP2 FAM3A GAD2 PBX3 PPP1CA PTPN9 RAB37 SH3GL1 TBRG4 TPD52 TPD52L1 TPD52L2 TUBB VARS2 | |
Entrez ID | 7163 | 114569 | |
HPRD ID | 04963 | 14351 | |
Ensembl ID | ENSG00000076554 | ENSG00000147676 | |
Uniprot IDs | P55327 | Q969L2 | |
PDB IDs | |||
Enriched GO Terms of Interacting Partners? | |||
Tagcloud ? | adjuvant
antigens
autoimmunity
broad
burden
class
considers
demonstrating
efforts
exhibiting
expected
focusing
highlighting
largest
obstacle
oncogenesis
overcome
overexpressed
perhaps
possibly
preclinical
preclude
presumed
promising
shed
subset
tolerance
understudied
vaccine
|
cease
chief
he4
imchief
immortomice
immortomouse
imspem
lineages
metaplasia
metaplasias
metaplastic
myelin
nonpermissive
owing
oxyntic
pepsinogen
permissive
preneoplastic
proliferate
rab3d
reliance
resemble
secrete
sole
spasmolytic
spem
stomach
tff2
transdifferentiation
|
|
Tagcloud (Difference) ? | adjuvant
antigens
autoimmunity
broad
burden
class
considers
demonstrating
efforts
exhibiting
expected
focusing
highlighting
largest
obstacle
oncogenesis
overcome
overexpressed
perhaps
possibly
preclinical
preclude
presumed
promising
shed
subset
tolerance
understudied
vaccine
|
cease
chief
he4
imchief
immortomice
immortomouse
imspem
lineages
metaplasia
metaplasias
metaplastic
myelin
nonpermissive
owing
oxyntic
pepsinogen
permissive
preneoplastic
proliferate
rab3d
reliance
resemble
secrete
sole
spasmolytic
spem
stomach
tff2
transdifferentiation
|
|
Tagcloud (Intersection) ? |